Skip to main content

Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence

Buy Article:

$51.00 plus tax (Refund Policy)



To establish the feasibility of conducting a placebo-controlled clinical trial of dexamphetamine replacement therapy for cocaine dependence and to obtain preliminary data. Design 

Double-blind randomized placebo-controlled trial. Participants 

Thirty cocaine-dependent injecting drug users. Intervention 

Subjects were assigned randomly to receive 60 mg/day dexamphetamine (n = 16) or placebo (n = 14) for 14 weeks. Measurements 

Immunoassay and mass spectrometric techniques were used to identify cocaine metabolites in urine. Subjects were screened using the Composite International Diagnostic Interview and DSM-IV. The Opiate Treatment Index, Brief Symptom Inventory, Severity of Dependence Scale and visual analogue craving scales were used to collect pre- and post-self-report data. Findings 

Treatment retention was equivalent between groups; however, outcomes favoured the treatment group with no improvements observed in the placebo control group. The proportion of cocaine-positive urine samples detected in the treatment group declined from 94% to 56% compared to no change in the placebo group (79% positive). While the improvements were not significant between groups, within-group analysis revealed that the treatment group reduced self-reported cocaine use (P = 0.02), reduced criminal activity (P = 0.04), reduced cravings (P < 0.01) and reduced severity of cocaine dependence (P < 0.01) with no within-group improvements found in the placebo group. Conclusions 

A definitive evaluation of the utility of dexamphetamine in the management of cocaine dependence is feasible and warranted.

Keywords: Cocaine dependence, dexamphetamine, randomized controlled trial, treatment

Document Type: Research Article


Affiliations: 1: National Drug and Alcohol Research Centre, University of New South Wales, 2: St Vincent's Hospital, 3: Kirketon Road Centre, Sydney Hospital 4: and Pacific Laboratory Medicine Services, Sydney, Australia4

Publication date: August 1, 2003


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more